{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T21:01:21Z","timestamp":1784667681750,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Chronic Granulomatous Disease (CGD) is a primary immunodeficiency that causes susceptibility to recurrent fungal and bacterial infections. The <jats:italic>CYBB<\/jats:italic> gene encodes gp91<jats:sup>phox<\/jats:sup> component of the Phagocytic Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and specifically, X-linked CGD is caused by mutations in the CYBB gene, located on the X chromosome. The aim of the study was to characterize functional and genetic mutations in X-linked CGD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Functional analysis was conducted on the whole blood of seventeen male individuals who were suspected to have X-linked chronic granulomatous disease (CGD). Flow cytometry was employed to assess the capacity of NADPH oxidase, measuring both H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> production and gp91<jats:sup>phox<\/jats:sup> protein expression in neutrophils. Additionally, DNA Sanger sequencing was performed for genetic analysis. The pathogenicity of novel mutations was assessed by pathogenicity prediction tools.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>Among the seventeen patients evaluated, five patients (P1, P2, P3, P4, and P5) displayed impaired H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> production by their neutrophils upon stimulation with Phorbol myristate acetate (PMA), accompanied by abnormal gp91<jats:sup>phox<\/jats:sup> expression. DNA sequencing of the CYBB gene identified specific mutations in each patient. In P1 and P2 (previously reported cases), a hemizygous missense mutation, c.925G\u2009&gt;\u2009A\/p.E309K was identified. In P3 and P4 (novel cases), hemizygous nonsense mutations, c.216T\u2009&gt;\u2009A\/p.C72X were found. Lastly, in P5 (also a novel case), a hemizygous missense mutation, c.732T\u2009&gt;\u2009G\/p.C244W was detected. These mutations reside in exons 9,3 and 7 of the <jats:italic>CYBB<\/jats:italic> gene, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The current study contributes to the understanding of the clinical and genetic spectrum associated with X-linked chronic granulomatous disease (CGD). It highlights the significance of early diagnosis in CGD and emphasizes the importance of lifelong prophylaxis to prevent severe infections.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13052-023-01496-7","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T13:02:33Z","timestamp":1690981353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel mutations in CYBB Gene Cause X-linked chronic Granulomatous Disease in Pakistani patients"],"prefix":"10.1186","volume":"49","author":[{"given":"Irum","family":"Gul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taj Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor ul","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naila","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehman","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid Niaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"issue":"5","key":"1496_CR1","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/j.1365-3083.2010.02501.x","volume":"73","author":"EB de Oliveira-Junior","year":"2011","unstructured":"de Oliveira-Junior EB, Bustamante J, Newburger PE, Condino-Neto A. The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes. Scand J Immunol. 2011;73(5):420\u20137.","journal-title":"Scand J Immunol"},{"issue":"3","key":"1496_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri1312","volume":"4","author":"JD Lambeth","year":"2004","unstructured":"Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol. 2004;4(3):181\u20139.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"1496_CR3","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/cmi.12322","volume":"16","author":"C Deffert","year":"2014","unstructured":"Deffert C, Cachat J, Krause KH. Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections. Cell Microbiol. 2014;16(8):1168\u201378.","journal-title":"Cell Microbiol"},{"issue":"4","key":"1496_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3858\/emm.2009.41.4.058","volume":"41","author":"J El-Benna","year":"2009","unstructured":"El-Benna J, Dang PM, Gougerot-Pocidalo MA, Marie JC, Braut-Boucher F. p47phox, the phagocyte NADPH oxidase\/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med. 2009;41(4):217\u201325.","journal-title":"Exp Mol Med"},{"issue":"2","key":"1496_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S1074-7613(00)80173-9","volume":"12","author":"J Tkalcevic","year":"2000","unstructured":"Tkalcevic J, Novelli M, Phylactides M, Iredale JP, Segal AW, Roes J. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity. 2000;12(2):201\u201310.","journal-title":"Immunity"},{"issue":"3","key":"1496_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/00005792-200005000-00004","volume":"79","author":"BH Segal","year":"2000","unstructured":"Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine. 2000;79(3):170\u2013200.","journal-title":"Medicine"},{"issue":"1","key":"1496_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.hoc.2012.11.002","volume":"27","author":"SM Holland","year":"2013","unstructured":"Holland SM. Chronic granulomatous disease. Hematol Oncol Clin N Am. 2013;27(1):89\u201399. viii.","journal-title":"Hematol Oncol Clin N Am"},{"key":"1496_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.micpath.2016.09.020","volume":"100","author":"TA Khan","year":"2016","unstructured":"Khan TA, Kalsoom K, Iqbal A, Asif H, Rahman H, Farooq SO, et al. A novel missense mutation in the NADPH binding domain of CYBB abolishes the NADPH oxidase activity in a male patient with increased susceptibility to infections. Microb Pathog. 2016;100:163\u20139.","journal-title":"Microb Pathog"},{"issue":"1\u20132","key":"1496_CR9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00439-004-1208-5","volume":"116","author":"MJ Stasia","year":"2005","unstructured":"Stasia MJ, Bordigoni P, Floret D, Brion JP, Bost-Bru C, Michel G, et al. Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease. Hum Genet. 2005;116(1\u20132):72\u201382.","journal-title":"Hum Genet"},{"issue":"1","key":"1496_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10875-006-9052-0","volume":"27","author":"LE Leiva","year":"2007","unstructured":"Leiva LE, Zelazco M, Oleastro M, Carneiro-Sampaio M, Condino-Neto A, Costa-Carvalho BT, et al. Primary immunodeficiency diseases in Latin America: the second report of the LAGID registry. J Clin Immunol. 2007;27(1):101\u20138.","journal-title":"J Clin Immunol"},{"issue":"3","key":"1496_CR11","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-2249.2007.03432.x","volume":"149","author":"P Wood","year":"2007","unstructured":"Wood P, Stanworth S, Burton J, Jones A, Peckham DG, Green T, et al. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol. 2007;149(3):410\u201323.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"1496_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0022-1759(89)90118-X","volume":"117","author":"M Hasui","year":"1989","unstructured":"Hasui M, Hirabayashi Y, Kobayashi Y. Simultaneous measurement by flow cytometry of phagocytosis and hydrogen peroxide production of neutrophils in whole blood. J Immunol Methods. 1989;117(1):53\u20138.","journal-title":"J Immunol Methods"},{"issue":"7","key":"1496_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1365-2362.2007.01828.x","volume":"37","author":"MY K\u00f6ker","year":"2007","unstructured":"K\u00f6ker MY, Sanal O, De Boer M, Tezcan I, Metin A, Ersoy F, et al. Mutations of chronic granulomatous disease in turkish families. Eur J Clin Invest. 2007;37(7):589\u201395.","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"1496_CR14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s10875-012-9859-9","volume":"33","author":"T Wada","year":"2013","unstructured":"Wada T, Muraoka M, Toma T, Imai T, Shigemura T, Agematsu K, et al. Rapid detection of intracellular p47phox and p67phox by flow cytometry; useful screening tests for chronic granulomatous disease. J Clin Immunol. 2013;33(4):857\u201364.","journal-title":"J Clin Immunol"},{"issue":"1","key":"1496_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40659-015-0028-5","volume":"48","author":"SK Ali","year":"2015","unstructured":"Ali SK, Doss CG, Kumar DT, Zhu H. CoagVDb: a comprehensive database for coagulation factors and their associated SAPs. Biol Res. 2015;48(1):35.","journal-title":"Biol Res"},{"key":"1496_CR16","doi-asserted-by":"publisher","first-page":"18568","DOI":"10.1038\/srep18568","volume":"5","author":"G Girotto","year":"2015","unstructured":"Girotto G, Scheffer DI, Morgan A, Vozzi D, Rubinato E, Di Stazio M, et al. PSIP1\/LEDGF: a new gene likely involved in sensorineural progressive hearing loss. Sci Rep. 2015;5:18568.","journal-title":"Sci Rep"},{"issue":"1","key":"1496_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/bja\/aew065","volume":"117","author":"AH Schiemann","year":"2016","unstructured":"Schiemann AH, Stowell KM. Comparison of pathogenicity prediction tools on missense variants in RYR1 and CACNA1S associated with malignant hyperthermia. Br J Anaesth. 2016;117(1):124\u20138.","journal-title":"Br J Anaesth"},{"issue":"3","key":"1496_CR18","doi-asserted-by":"publisher","first-page":"e0150772","DOI":"10.1371\/journal.pone.0150772","volume":"11","author":"M Martins-Pinheiro","year":"2016","unstructured":"Martins-Pinheiro M, Lima WC, Asif H, Oller CA, Menck CF. Evolutionary and Functional Relationships of the dha regulon by genomic context analysis. PLoS ONE. 2016;11(3):e0150772.","journal-title":"PLoS ONE"},{"key":"1496_CR19","doi-asserted-by":"crossref","unstructured":"Magnani F, Nenci S, Millana Fananas E, Ceccon M, Romero E. Crystal structures and atomic model of NADPH oxidase. 2017;114(26):6764\u20139.","DOI":"10.1073\/pnas.1702293114"},{"issue":"3","key":"1496_CR20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","volume":"234","author":"A Sali","year":"1993","unstructured":"Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234(3):779\u2013815.","journal-title":"J Mol Biol"},{"issue":"1","key":"1496_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2249.2009.03985.x","volume":"158","author":"H Esquivel-Sol\u00eds","year":"2009","unstructured":"Esquivel-Sol\u00eds H, Qui\u00f1ones-Falconi F, Zarain-Herzberg A, Amieva-Fern\u00e1ndez RI, L\u00f3pez-Vidal Y. Impaired activation of Stat1 and c-Jun as a possible defect in macrophages of patients with active tuberculosis. Clin Exp Immunol. 2009;158(1):45\u201354.","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"1496_CR22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bcmd.2010.07.012","volume":"45","author":"D Roos","year":"2010","unstructured":"Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. 2010;45(3):246\u201365.","journal-title":"Blood Cells Mol Dis"},{"issue":"5","key":"1496_CR23","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s004390000288","volume":"106","author":"F Ishibashi","year":"2000","unstructured":"Ishibashi F, Nunoi H, Endo F, Matsuda I, Kanegasaki S. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency. Hum Genet. 2000;106(5):473\u201381.","journal-title":"Hum Genet"},{"issue":"4","key":"1496_CR24","doi-asserted-by":"publisher","first-page":"e5234","DOI":"10.1371\/journal.pone.0005234","volume":"4","author":"JM n den Berg","year":"2009","unstructured":"n den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the european experience. PLoS ONE. 2009;4(4):e5234.","journal-title":"PLoS ONE"},{"issue":"3","key":"1496_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00005792-200005000-00003","volume":"79","author":"JA Winkelstein","year":"2000","unstructured":"Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine. 2000;79(3):155\u201369.","journal-title":"Medicine"},{"issue":"7","key":"1496_CR26","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1084\/jem.20060085","volume":"203","author":"O Filipe-Santos","year":"2006","unstructured":"Filipe-Santos O, Bustamante J, Haverkamp MH, Vinolo E, Ku CL, Puel A, et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med. 2006;203(7):1745\u201359.","journal-title":"J Exp Med"},{"key":"1496_CR27","doi-asserted-by":"publisher","first-page":"687538","DOI":"10.3389\/fped.2021.687538","volume":"9","author":"S Al-Hammadi","year":"2021","unstructured":"Al-Hammadi S, Yahya AM, Al-Amri A, Shibli A, Balhaj GB, Tawil MI, et al. Case Report: BCG-Triggered Hemophagocytic Lymphohistiocytosis in an infant with X-Linked recessive mendelian susceptibility to Mycobacterial Disease due to a variant of chronic Granulomatous Disease. Front Pead. 2021;9:687538.","journal-title":"Front Pead"},{"issue":"5","key":"1496_CR28","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.jaci.2013.05.039","volume":"132","author":"MY K\u00f6ker","year":"2013","unstructured":"K\u00f6ker MY, Camc\u0131o\u011flu Y, van Leeuwen K, K\u0131l\u0131\u00e7 S, Barlan I, Y\u0131lmaz M, et al. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 turkish patients. J Allergy Clin Immunol. 2013;132(5):1156\u201363e5.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"1496_CR29","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s10875-011-9567-x","volume":"31","author":"F Fattahi","year":"2011","unstructured":"Fattahi F, Badalzadeh M, Sedighipour L, Movahedi M, Fazlollahi MR, Mansouri SD, et al. Inheritance pattern and clinical aspects of 93 iranian patients with chronic granulomatous disease. J Clin Immunol. 2011;31(5):792\u2013801.","journal-title":"J Clin Immunol"},{"issue":"2","key":"1496_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/pbc.20455","volume":"46","author":"P Agudelo-Fl\u00f3rez","year":"2006","unstructured":"Agudelo-Fl\u00f3rez P, Prando-Andrade CC, L\u00f3pez JA, Costa-Carvalho BT, Quezada A, Espinosa FJ, et al. Chronic granulomatous disease in latin american patients: clinical spectrum and molecular genetics. Pediatr Blood Cancer. 2006;46(2):243\u201352.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"1496_CR31","first-page":"377","volume":"191","author":"F Morel","year":"2007","unstructured":"Morel F. [Molecular aspects of chronic granulomatous disease. \u201cthe NADPH oxidase complex\u201d]. Bull de l\u2019Academie nationale de Med. 2007;191(2):377\u2013. \u2013 90; discussion 90 \u2013 2.","journal-title":"Bull de l\u2019Academie nationale de Med"},{"issue":"3","key":"1496_CR32","first-page":"297","volume":"62","author":"W Hussain","year":"2012","unstructured":"Hussain W, Batool A, Ahmed TA, Bashir MM. Severe combined immunodeficiency due to adenosine deaminase deficiency. JPMA The Journal of the Pakistan Medical Association. 2012;62(3):297\u20139.","journal-title":"JPMA The Journal of the Pakistan Medical Association"},{"issue":"1","key":"1496_CR33","first-page":"165","volume":"23","author":"MO Khan","year":"2011","unstructured":"Khan MO, Memon AI, Zubairi AB, Imam AA. Undetected common variable immune deficiency in a young adult of pakistani descent. J Ayub Med Coll Abbottabad. 2011;23(1):165\u20136.","journal-title":"J Ayub Med Coll Abbottabad"},{"issue":"8","key":"1496_CR34","first-page":"570","volume":"23","author":"AF Saleem","year":"2013","unstructured":"Saleem AF, Ali Khawaja RD, Shaikh AS, Ali SA, Mehdi Zaidi AK. Severe combined immune deficiency syndrome. J Coll Physicians Surgeons\u2013Pakistan : JCPSP. 2013;23(8):570\u20133.","journal-title":"J Coll Physicians Surgeons\u2013Pakistan : JCPSP"},{"issue":"4","key":"1496_CR35","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.exphem.2006.01.005","volume":"34","author":"H von Goessel","year":"2006","unstructured":"von Goessel H, Hossle JP, Seger R, Gungor T. Characterization of 17 new cases of X-linked chronic granulomatous disease with seven novel mutations in the CYBB gene. Exp Hematol. 2006;34(4):528\u201335.","journal-title":"Exp Hematol"},{"issue":"5","key":"1496_CR36","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s00439-004-1173-z","volume":"115","author":"C Bionda","year":"2004","unstructured":"Bionda C, Li XJ, van Bruggen R, Eppink M, Roos D, Morel F, et al. Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells. Hum Genet. 2004;115(5):418\u201327.","journal-title":"Hum Genet"},{"issue":"5","key":"1496_CR37","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1086\/422993","volume":"39","author":"BE Marciano","year":"2004","unstructured":"Marciano BE, Wesley R, De Carlo ES, Anderson VL, Barnhart LA, Darnell D, et al. Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis. 2004;39(5):692\u20139.","journal-title":"Clin Infect Dis"},{"issue":"24","key":"1496_CR38","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa021931","volume":"348","author":"JI Gallin","year":"2003","unstructured":"Gallin JI, Alling DW, Malech HL, Wesley R, Koziol D, Marciano B, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med. 2003;348(24):2416\u201322.","journal-title":"N Engl J Med"},{"issue":"1","key":"1496_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0022-3476(83)80798-7","volume":"103","author":"RS Weening","year":"1983","unstructured":"Weening RS, Kabel P, Pijman P, Roos D. Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease. J Pediatr. 1983;103(1):127\u201330.","journal-title":"J Pediatr"},{"issue":"3","key":"1496_CR40","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/infdis\/162.3.723","volume":"162","author":"DM Margolis","year":"1990","unstructured":"Margolis DM, Melnick DA, Alling DW, Gallin JI. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis. 1990;162(3):723\u20136.","journal-title":"J Infect Dis"},{"key":"1496_CR41","doi-asserted-by":"crossref","unstructured":"Oikonomopoulou Z, Shulman S, Mets M, Katz B. Correction to: chronic granulomatous disease: an updated experience, with emphasis on newly recognized features. 2022;42(7):1420.","DOI":"10.1007\/s10875-022-01370-x"},{"key":"1496_CR42","doi-asserted-by":"crossref","unstructured":"Gunderman L, Brown J, Chaudhury S, O\u2019Gorman M, Fuleihan R, Khanolkar A. Co-occurring X-Linked agammaglobulinemia and X-Linked chronic Granulomatous Disease: two isolated pathogenic variants in one patient. 2023;11(3).","DOI":"10.3390\/biomedicines11030959"},{"issue":"9","key":"1496_CR43","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/j.ijid.2011.05.002","volume":"15","author":"XF Gao","year":"2011","unstructured":"Gao XF, Yang ZW, Li J. Adjunctive therapy with interferon-gamma for the treatment of pulmonary tuberculosis: a systematic review. Int J Infect Dis. 2011;15(9):e594\u2013600.","journal-title":"Int J Infect Dis"},{"issue":"10","key":"1496_CR44","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1002\/pbc.26098","volume":"63","author":"TA Khan","year":"2016","unstructured":"Khan TA, Schimke LF, Amaral EP, Ishfaq M, Barbosa Bonfim CC, Rahman H, et al. Interferon-gamma reduces the proliferation of M. tuberculosis within macrophages from a patient with a novel hypomorphic NEMO mutation. Pediatr Blood Cancer. 2016;63(10):1863\u20136.","journal-title":"Pediatr Blood Cancer"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-023-01496-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-023-01496-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-023-01496-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T13:04:57Z","timestamp":1690981497000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-023-01496-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1186\/s13052-023-01496-7","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,2]]},"assertion":[{"value":"21 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"<b>Ethics approval and consent to participate<\/b>.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental protocols were approved by the ethical committee of Kohat University of Science and Technology (KUST) under reference number (KUST\/Ethical committee\/18\u2009\u2212\u20092). All methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"<b>Consent for publication<\/b>.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication was obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"<b>Competing interests<\/b>.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare no conflict of interest.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"95"}}